drugset / Trial / NCT04855006

Transplantation of Vaginal Mikrobiome

NCT04855006 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Vaginal dysbiosis is a common condition among women. Vaginal dysbiosis covers imbalances in the vaginal flora, caused by the composition of microbes, bacteria, viruses and fungi. Dysbiosis occurs in about 16% of all women in Denmark. A large proportion of women who have vaginal dysbiosis do not experience any symptoms. However, vaginal dysbiosis can present challenges in several contexts, including a higher tendency for bacterial infections in the female genitals, lower chances of pregnancy in women undergoing fertility treatment, just as it can predispose to premature birth. This project is aimed at women aged 18-40, who wants to participate in a study to investigate whether, by transplanting vaginal secretion from one woman with a normal vaginal bacterial flora to another woman with an imbalance in the vaginal bacterial flora (called vaginal dysbiosis), can establish a normal vaginal bacterial flora in the recipient of the transplant. The study will also explore weather genetic, immunological, hormonal, metabolic, health behaviors and clinical factors have significance on whether a normal vaginal flora is achieved after transplantation.

Timeline

Start
2021-06-01
Primary completion
2023-01-01
Completion
2023-03-24

Outcome

Missed primary endpoint

paper The primary outcome showed no significant difference in dysbiosis resolution between active and placebo groups (HR 0·65; 95% CI 0·20-2·16, p=0·49). PMID 41905375 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Vaginal Microbiome Transplant Unknown — —

Indications

No indication recorded.